BIOMED PHARMACOTHER 润色咨询

BIOMEDICINE & PHARMACOTHERAPY

出版年份:1982 年文章数:8228 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:10.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-29 120af76fm06(暂无昵称)

    6月20日提交的hanxx 2018-06-29 00:00:00 发表:
    你是什么时候提交的啊

    hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-28 120af76fm06(暂无昵称)

    请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....chenerfei 2018-06-28 00:00:00 发表:
    Wb重复三次的.unchorped band.还是必须的

    chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-27 一旺百旺

    初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-27 霸主CC

    都涨了.这个期刊还是不错的taf666 2018-05-07 00:00:00 发表:
    请问版面费***啊

    taf666 2018-05-07 00:00:00 发表: 请问版面费***啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-27 nnsz007

    10天了pubmed上还没搜到-quyikun2008 2018-06-22 发表::
    很快.二周内差不多
    quyikun2008 2018-06-22 00:00:00 发表:
    很快.二周内差不多

    quyikun2008 2018-06-22 发表:: 很快.二周内差不多

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-22 quyikun2008

    很快.二周内差不多nnsz007 2018-06-17 01:24:00 发表:
    今天刚接收.多久online?

    nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-17 nnsz007

    今天刚接收,多久online?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-14 探宝者

    Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-03 周崇明

    同问幽硕 2018-06-01 00:00:00 发表:
    您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?

    幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=558658, encodeId=b68f558658e9, content=6月20日提交的<span class="quote">hanxx 2018-06-29 00:00:00 发表:<br>你是什么时候提交的啊</span>, beContent=hanxx 2018-06-29 00:00:00 发表: 你是什么时候提交的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558587, encodeId=bd2755858e86, content=请问是在投稿的时候提交wb重复组吗.我的状态已经邀请审稿人了.现在提交应该迟了吧....<span class="quote">chenerfei 2018-06-28 00:00:00 发表:<br>Wb重复三次的.unchorped band.还是必须的</span>, beContent=chenerfei 2018-06-28 00:00:00 发表: Wb重复三次的.unchorped band.还是必须的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bd22199612, createdName=120af76fm06(暂无昵称), createdTime=Thu Jun 28 00:00:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558495, encodeId=d193558495c4, content=初审一般一个月。然后一般还会经历二次审核。大概也是不到一个月的时间。最近要求有点升高。不好中了这个期刊。最新的投稿说明。western blot要求提供原始的三次重复的原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/UXXWeP8KqJ7VMWToVFVAibyRmYHuxQe9IOTQ6cDxKzSmXQCbpH0zdafSyE9Cp5SicIT5iarhuAjZPRKVc7APjGTzQ/132, createdBy=20922028332, createdName=一旺百旺, createdTime=Wed Jun 27 14:36:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558492, encodeId=775c55849263, content=都涨了.这个期刊还是不错的<span class="quote">taf666 2018-05-07 00:00:00 发表:<br>请问版面费***啊</span>, beContent=taf666 2018-05-07 00:00:00 发表: 请问版面费***啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1962153909, createdName=霸主CC, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558507, encodeId=6be055850e39, content=10天了pubmed上还没搜到-<span class="quote">quyikun2008 2018-06-22 发表::<br>很快.二周内差不多</span><span class="quote">quyikun2008 2018-06-22 00:00:00 发表:<br>很快.二周内差不多</span>, beContent=quyikun2008 2018-06-22 发表:: 很快.二周内差不多, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Wed Jun 27 00:00:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558204, encodeId=b62655820449, content=很快.二周内差不多<span class="quote">nnsz007 2018-06-17 01:24:00 发表:<br>今天刚接收.多久online?</span>, beContent=nnsz007 2018-06-17 01:24:00 发表: 今天刚接收.多久online?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fe01544891, createdName=quyikun2008, createdTime=Fri Jun 22 00:00:00 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558058, encodeId=3a1b5580580b, content=今天刚接收,多久online?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=764574971, createdName=nnsz007, createdTime=Sun Jun 17 01:24:00 CST 2018, time=2018-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557930, encodeId=4f6055e930c7, content=Based on information provided the embargo period/end date is 12 months. 请问这句话是指12月禁运期过了才可以发表吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/29/a4cb85d2163b564c210b12e4365e66eb.jpg, createdBy=7f442000653, createdName=探宝者, createdTime=Thu Jun 14 00:00:00 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557534, encodeId=f1b955e53415, content=同问<span class="quote">幽硕 2018-06-01 00:00:00 发表:<br>您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?</span>, beContent=幽硕 2018-06-01 00:00:00 发表: 您好.最近想投biomedicine pharmacotherapy这个杂志.不知道对中药复方有没有指纹图谱的要求.还有几张图片有无限制呢?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/3fDyEZXGREIN2iangVs1ib46Bn2SUEpCBmhFVAoH8zwCJqMsKjDJFbg9Y1AwLNPEr6FsROa5RlPr6icdHp8Geq64g/132, createdBy=8cac2364882, createdName=周崇明, createdTime=Sun Jun 03 00:00:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557448, encodeId=2fed55e44809, content=请问复方需要指纹图谱等分析么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbdf2081177, createdName=幽硕, createdTime=Fri Jun 01 09:24:00 CST 2018, time=2018-06-01, status=1, ipAttribution=)]
    2018-06-01 幽硕

    请问复方需要指纹图谱等分析么?

    0

共500条页码: 50/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分